Literature DB >> 8711068

Ontogenetic studies of tolerance development: effects of chronic morphine on the hypothalamic-pituitary-adrenal axis.

P J Little1, C M Kuhn.   

Abstract

Endogenous opiates are important regulators of the hypothalamic-pituitary-adrenal (HPA) axis in rats. Tolerance clearly develops to morphine-induced stimulation of the HPA axis in adult rats (Ignar and Kuhn 1990). The goal of the present study was to determine whether tolerance to morphine-induced stimulation of the HPA axis developed in neonatal and weanling rats treated chronically with morphine. Rats were injected with morphine or saline between days 4-8 postnatal (pups) or days 21-25 (weanlings) and tolerance assessed by determining dose-response curves for ACTH and corticosterone secretion following an acute morphine challenge. Weanlings displayed marked tolerance to the stimulation of ACTH and corticosterone secretion by morphine. Tolerance was also observed in pups to morphine-stimulated ACTH and corticosterone release. These findings suggest that the relative adaptability of the HPA axis to chronic morphine in neonatal and weanling rats is similar.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8711068     DOI: 10.1007/BF02246445

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  16 in total

1.  beta-Endorphin stimulates corticosterone synthesis in isolated rat adrenal cells.

Authors:  G Shanker; R K Sharma
Journal:  Biochem Biophys Res Commun       Date:  1979-01-15       Impact factor: 3.575

2.  Ontogeny of mu- and kappa-opiate receptor control of the hypothalamo-pituitary-adrenal axis in rats.

Authors:  W T Adamson; R T Windh; S Blackford; C M Kuhn
Journal:  Endocrinology       Date:  1991-08       Impact factor: 4.736

3.  Evidence for opiate tolerance in newborn rats.

Authors:  H Van Praag; H Frenk
Journal:  Brain Res Dev Brain Res       Date:  1991-05-20

4.  Effects of acute and chronic adminstration of narcotic analgesics on growth hormone and corticotrophin (ACTH) secretion in rats.

Authors:  N Kokka; J F Garcia; H W Elliott
Journal:  Prog Brain Res       Date:  1973       Impact factor: 2.453

5.  Antagonistic effect of methadone on steroidogenesis and the adenylate cyclase system in isolated rat adrenocortical cells.

Authors:  C A Harrington; R W Farmer
Journal:  Biochem Biophys Res Commun       Date:  1974-09-23       Impact factor: 3.575

6.  Morphine-induced downregulation of mu-opioid receptors in neonatal rat brain.

Authors:  A Tempel; J Habas; W Paredes; G A Barr
Journal:  Brain Res       Date:  1988-06-01       Impact factor: 3.252

7.  Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine.

Authors:  J C Buckingham; T A Cooper
Journal:  Neuroendocrinology       Date:  1984-05       Impact factor: 4.914

8.  The ontogeny of opiate tolerance and withdrawal in infant rats.

Authors:  M S Fanselow; C P Cramer
Journal:  Pharmacol Biochem Behav       Date:  1988-10       Impact factor: 3.533

9.  Tolerance and withdrawal to chronic morphine treatment in the week-old rat pup.

Authors:  G A Barr; S Wang
Journal:  Eur J Pharmacol       Date:  1992-04-29       Impact factor: 4.432

10.  Naloxone inhibits and morphine potentiates the adrenal steroidogenic response to ACTH.

Authors:  J P Heybach; J Vernikos
Journal:  Eur J Pharmacol       Date:  1981-10-15       Impact factor: 4.432

View more
  2 in total

1.  Next generation effects of female adolescent morphine exposure: sex-specific alterations in response to acute morphine emerge before puberty.

Authors:  Fair M Vassoler; Nicole L Johnson-Collins; Lindsay M Carini; Elizabeth M Byrnes
Journal:  Behav Pharmacol       Date:  2014-04       Impact factor: 2.293

Review 2.  The effects of opioids and opioid analogs on animal and human endocrine systems.

Authors:  Cassidy Vuong; Stan H M Van Uum; Laura E O'Dell; Kabirullah Lutfy; Theodore C Friedman
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.